Company / Accounts Receivable
SOLENO THERAPEUTICS INC Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$28.2M
FY2025
5-year range
$28.2M / $28.2M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#85 of 115
Health Care
What the data says
At $28M, SOLENO THERAPEUTICS INC's accounts receivable ranks #85 of 115 in the Health Care sector. Improved from $133,337 to $28M over the past 9 years.
Based on SEC 10-K filings.
$28M in FY2025.
Improved from $133,337 to $28M over the past 9 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#85 of 115 in Health CareTop 74% of 115This company $28.2M Sector average $1.1B
▼
-97.5% below sector average
Key checks
Key Insights
- Ranks #85 out of 115 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.2M | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0 | - |
| FY2017 | - | - |
| FY2016 | $133.3K | -14.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026